WahanaRiau.com - Global partnership

Berita Politik Peristiwa Ekonomi Otomotif Olahraga Teknologi Gaya Hidup Travel Video Media OutReach Globenewswire Advertorial Pilihan Editor Terpopuler Indeks

Berita
Peristiwa
Politik
Ekonomi
Teknologi
Otomotif
Olahraga
Gaya Hidup
Travel
More

Global partnership

Index

Globenewswire

As IBS 2026 Approaches, LEPAS Unfolds Its “Elegance Moves the World” Trilogy

Kamis, 09 April 2026 - 20:24:02 Wib

Globenewswire

COMSOL Conference 2026 Schedule Announced, with Stops in the UK, U.S., Japan, and India

Kamis, 12 Maret 2026 - 20:04:18 Wib

Globenewswire

Unlocking Every Potential: Papua New Guinea’s Drive for an Inclusive Workforce

Jumat, 05 Desember 2025 - 04:56:23 Wib

Global partnership

As IBS 2026 Approaches, LEPAS Unfolds Its “Elegance Moves the World” Trilogy

COMSOL Conference 2026 Schedule Announced, with Stops in the UK, U.S., Japan, and India

Unlocking Every Potential: Papua New Guinea’s Drive for an Inclusive Workforce

Terpopuler

U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
Dibaca: 133 Kali

Coralogix Adds Macquarie Capital Venture Capital as Investor to Accelerate Expansion Across Australia and New Zealand
Dibaca: 175 Kali

Coventry’s LILY Funding Program Reaches $1 Billion in Life Insurance-Backed Financing
Dibaca: 129 Kali

Founder Group Announces Investment in Nichcom Go Sdn. Bhd., Operator of SpacePlus EV Charging Network, to Expand Market Leadership in EV Industry
Dibaca: 136 Kali

Grand Challenges Canada dan AVPN Meluncurkan Nexa Lighthouse untuk Mendanai Inovasi Iklim dan Kesehatan di Kawasan Asia dan Pasifik
Dibaca: 125 Kali

Terkini

Binzhou Unveils "Trade-In" Housing Models to Stabilize Real Estate Market

Hardcore Quality Conquers Global Users: GREE Premium RACs Top the 2025 Global Sales

Only 49% of Singaporeans Feel Prepared for the Next Decade

JOYY Delivers YoY and QoQ Growth in Total Revenues as Diversified Businesses Sustain Strong Momentum

U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma

Global partnership

Terpopuler

U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma Dibaca: 133 Kali

Coralogix Adds Macquarie Capital Venture Capital as Investor to Accelerate Expansion Across Australia and New Zealand Dibaca: 175 Kali

Coventry’s LILY Funding Program Reaches $1 Billion in Life Insurance-Backed Financing Dibaca: 129 Kali

Founder Group Announces Investment in Nichcom Go Sdn. Bhd., Operator of SpacePlus EV Charging Network, to Expand Market Leadership in EV Industry Dibaca: 136 Kali

Grand Challenges Canada dan AVPN Meluncurkan Nexa Lighthouse untuk Mendanai Inovasi Iklim dan Kesehatan di Kawasan Asia dan Pasifik Dibaca: 125 Kali

Terkini

U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
Dibaca: 133 Kali

Coralogix Adds Macquarie Capital Venture Capital as Investor to Accelerate Expansion Across Australia and New Zealand
Dibaca: 175 Kali

Coventry’s LILY Funding Program Reaches $1 Billion in Life Insurance-Backed Financing
Dibaca: 129 Kali

Founder Group Announces Investment in Nichcom Go Sdn. Bhd., Operator of SpacePlus EV Charging Network, to Expand Market Leadership in EV Industry
Dibaca: 136 Kali

Grand Challenges Canada dan AVPN Meluncurkan Nexa Lighthouse untuk Mendanai Inovasi Iklim dan Kesehatan di Kawasan Asia dan Pasifik
Dibaca: 125 Kali